IDF has signed two strategic training collaborations with Sanofi General Medicines, and Sanofi Global Health Unit (GHU) to improve access to diabetes care through training aimed at building capacity among healthcare professionals (HCPs) in low and middle-income countries (LMICs).
According to the IDF Diabetes Atlas 10th edition, the majority of the more than half a billion individuals now living with diabetes worldwide are found in low and middle-income countries (LMICs). This number is predicted to reach 783 million by 2045, with the vast majority (94%) of the total increase occurring in LMICs – a total of 233 million more people with diabetes. The need for a decentralised management of diabetes care, involving HCPs beyond specialists and for a skilled diabetes workforce is therefore particularly urgent in these countries.
IDF and Sanofi recognise that achieving early diagnosis and equitable access to ongoing diabetes care require a collective effort, involving local and national health systems, inter-governmental agencies, and civil society.
Sanofi is strengthening its long-standing commitment to improve access to diabetes care in LMICs and underserved communities across all geographies through close collaboration with local governments, multi-stakeholders, and partners like IDF. This is done through different access models as part of comprehensive diabetes care programmes to ensure that the specific needs of these healthcare systems and local populations are met.